ArticleIBRO neuroscience reports2026
Mongolian warm acupuncture improves colonic barrier function and immune responses via the TLR4/MyD88/NF-κB pathway in insomnia rats.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insomnia is a prevalent sleep disorder associated with intestinal barrier dysfunction and immune dysregulation. Mongolian warm acupuncture (MWA) has shown therapeutic potential in insomnia; however, its effects on intestinal permeability and underlying mechanisms remain unclear. In this study, an insomnia rat model was established using chronic unpredictable mild stress combined with para-chlorophenylalanine (PCPA). To evaluate the therapeutic effects of MWA, comparative analysis was conducted among different groups, including Control, Model, MWA, Estazolam, and sham MWA groups. MWA group showed significantly improvement on sleep quality, cognitive performance, and anxiety-like behavior and alleviated colonic tissue damage. MWA treatment attenuated intestinal barrier dysfunction by modulating the expression of ZO-1, Occludin, and Claudin-4. In addition, MWA reduced inflammatory responses by decreasing TNF-α, IL-1β, and IL-6 levels while increasing IL-22 expression. Furthermore, MWA suppressed activation of the TLR4/MyD88/NF-κB signaling pathway. These findings suggest that MWA exerts protective effects against insomnia-associated intestinal barrier dysfunction and inflammation and may represent a promising non-pharmacological therapeutic strategy for insomnia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.